At the Envision Summit 2025 in San Juan, Puerto Rico, Mike Farkas, MD, discussed gene therapy research for retinal ...
7h
News Medical on MSNNew genetic medicine offers life-changing vision improvements for blind childrenFour young children have gained life-changing improvements in sight following treatment with a pioneering new genetic medicine through UCL Institute of Ophthalmology and Moorfields Eye Hospital, with ...
Cash-strapped gene-therapy company Bluebird bio agreed to be acquired by private-equity firms Carlyle Group and SK Capital Partners in a deal potentially worth up to $96 million.
Senate committee members heard arguments on a bill that would place a 10-year pause on administering mRNA vaccines in Idaho on Monday but did not take a vote.
The procedure, developed by UCL scientists, consists of injecting healthy copies of the gene into the retina, at the back of ...
The move comes after Commission Chairman Clint Didier invited a group of vaccine skeptics to speak at two recent meetings. It’s the same group behind recent pushes in Idaho to stop offering the ...
The Franklin County Board of Commissioners has passed a resolution urging the Benton Franklin Health District (BFHD) to cease providing, funding, and promoting gene-therapy vaccines until ...
Workplace Bullying's Sleep Impact Spreads to Partners, reveals studyWorkplace bullying affects not only the employee’s sleep ...
19h
Hosted on MSNBlind 6-year-old Connecticut boy sees for the first time after groundbreaking gene therapyJace, 4, from Connecticut, was registered legally blind and only just able to distinguish between dark and light before undergoing treatment at Moorfields Eye Hospital in London ...
16h
The Punch on MSNAdvocating increased funding for sickle cell research: A call to actionSickle cell disease is a severe, inherited blood disorder that primarily affects people of African, Mediterranean, Middle Eastern, and Indian descent.Despite its widespread impact, SCD research has ...
Dr. Chandler Park discusses the importance of genetic testing and personalized care in patients with genitourinary cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results